These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Validation of an HPLC-MS-MS method for the determination of urinary S-benzylmercapturic acid and S-phenylmercapturic acid.
    Author: B'Hymer C.
    Journal: J Chromatogr Sci; 2011 Aug; 49(7):547-53. PubMed ID: 21801486.
    Abstract:
    A high-performance liquid chromatography-tandem mass spectrometric (HPLC-MS-MS) method is presented and evaluated for the determination of S-benzylmercapturic acid (S-BMA) and S-phenylmercapturic acid (S-PMA) in human urine. Both of these compounds are important for occupational health owing to their use as biomarkers of exposure to toluene and benzene, respectively. Toluene is used extensively as a solvent, and the health hazards of benzene have been well established. The optimized urine sample preparation scheme consists of solid-phase extraction (SPE) followed by an acetone wash. The chromatographic analysis consists of a reversed-phase gradient system, which uses electrospray ionization in negative-ion mode with a triple-quadrupole mass spectrometric detector. Accuracy and precision of this method are demonstrated by a series of recovery studies of spiked human urine and synthetic urine substitute. Spike levels at 1, 2, 6, 8, and 30 ng/mL for both analytes demonstrate average recoveries (accuracy) ranging from 99 to 110%. Precision as measured by the relative standard deviation (%RSD) of multiple samples (n=9) at each concentration level was 5.3% or less for both analytes in urine. The limit of detection (LOD) is approximately 0.2 ng/mL for S-BMA and S-PMA. This data, other figures of merit and other factors, such as ion suppression of the electrospray ionization source, are discussed.
    [Abstract] [Full Text] [Related] [New Search]